Table 1.
Demographic and clinical characteristics of 105 patients with classic KSHV/HHV-positive PEL
| Number (%) | ||
|---|---|---|
| Demographic characteristics | ||
| Male | 90 (85.7) | |
| Female | 15 (14.3) | |
| Median age, years | 77 | |
| Country of origin (n = 88) | ||
| Italy | 21 (23.9) | |
| Greece | 6 (6.9) | |
| Spain, Portugal | 5 (5.7) | |
| France | 3 (3.4) | |
| Turkey | 2 (2.3) | |
| Israel, Lebanon | 4 (4.5) | |
| Algeria, Morocco | 5 (5.7) | |
| Eastern Europea | 6 (6.9) | |
| Taiwan | 16 (18.2) | |
| Japan | 8 (9.1) | |
| South Korea | 6 (6.9) | |
| Othersb | 6 (6.9) | |
|
| ||
| Clinical characteristcs | ||
| Comorbidities (n = 95) | ||
| Heart failure | 30 (31.6) | |
| Liver cirrhosis | 15 (15.8) | |
| KS and/or MCD | 11 (10.5) | |
| Malignancy (n = 93) | 23c | |
| Colon | 4 | |
| Lymphoid neoplasms d | 4 | |
| Stomach e | 3 | |
| Breast | 3 | |
| Prostate | 3 | |
| Lung | 2 | |
| Oral cavity | 2 | |
| Others f | 2 | |
|
| ||
| Number of cavities involved | ||
| One | 61 (59.1) | |
| Pleural | 41 (67.2) | |
| Peritoneal | 16 (26.2) | |
| Pericardial | 4 (6.6) | |
| Two or more | 44 (41.2) | |
n, number of patients with available data; KS, Kaposi sarcoma; MCD, multicentric Castleman disease;
a
Russia (n=4), Eastern Europe, not otherwise specified (n=2);
b
Hong Kong, Argentina, Colombia, Peru, Philippines, Mali;
c
Referring to events not patients;
d
Hodgkin’s lymphoma (n=3), chronic lymphocitic leukaemia (n=1);
e
Gastrointestinal stromal tumor (n=1);
F
Liver (n=1), ovary (n=1).